文献速递血液净化与透析

MAIT细胞介导腹膜透析相关腹膜纤维化的免疫机制及靶向治疗

Mucosal-Associated Invariant T (MAIT) Cell-Mediated Immune Mechanisms of Peritoneal Dialysis-Induced Peritoneal Fibrosis and Therapeutic Targeting.
PubMed 文献 · J Am Soc Nephrol · 2025-01-28

本研究通过单细胞RNA测序、组织学成像和流式细胞术,发现长期腹膜透析增强腹膜MAIT细胞(尤其MAIT17亚型)活化,经TCRVα7.2-MR1信号诱导间皮细胞高糖酵解和纤维化。遗传敲除或乙酰-6-甲酰蝶呤抑制MAIT细胞可减轻小鼠腹膜纤维化。

要点

  • 长期PD患者腹膜MAIT细胞活化增强,MAIT17亚型促纤维化。
  • MAIT细胞通过MR1-mTORC1通路诱导间皮细胞高糖酵解。
  • 药物乙酰-6-甲酰蝶呤或Mr1敲除可减轻腹膜纤维化。

核心结论

  • MAIT细胞是腹膜透析诱导腹膜纤维化的关键驱动因素,靶向MAIT细胞或MR1-MAIT相互作用可减轻纤维化。

研究设计与样本

  • 研究采用单细胞RNA测序和流式细胞术分析长期PD患者腹膜MAIT细胞,并结合体外模型和Mr1敲除小鼠验证机制。

主要发现

  • 长期PD显著增强MAIT细胞活化,尤其促炎MAIT17亚型。
  • 活化MAIT细胞与间皮细胞MR1结合,经mTORC1通路触发高糖酵解,导致纤维化。
  • 遗传敲除Mr1或乙酰-6-甲酰蝶呤抑制MAIT细胞功能,有效减轻纤维化。

临床怎么用

  • 抑制MAIT细胞功能或阻断MR1-MAIT相互作用可能成为防治腹膜透析相关腹膜纤维化的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Peritoneal mucosal-associated invariant T (MAIT) cells were characterized by single-cell RNA sequencing, histological imaging, and flow cytometry. Activation of MAIT cells modulated glucose metabolism in mesothelial cells by TCRVα7.2-MHC class 1–related protein 1 signaling and triggered peritoneal fibrogenesis. Pharmacological inhibition of MAIT cell function by acetyl-6-formylpterin mitigated peritoneal fibrosis. BACKGROUND: Peritoneal fibrosis is a serious complication of long-term peritoneal dialysis (PD) and abdominal surgeries, yet effective treatments remain elusive. Given the known roles of mucosal-associated invariant T (MAIT) cells in immune responses and fibrotic diseases, we investigated their involvement in PD-induced peritoneal fibrosis to identify potential therapeutic targets. METHODS: We used single-cell RNA sequencing and flow cytometry to characterize the activation and function of peritoneal MAIT cells in patients undergoing long-term PD. Our investigation focused on the molecular pathways activated by these cells, particularly the MHC class 1–related protein 1 (MR1)-mediated interaction with mesothelial cells and subsequent activation of the mTOR complex 1 signaling pathway. We further assessed the effect of inhibiting MAIT cells on fibrogenesis using both in vitro models and Mr1 knockout mice. RESULTS: Our study revealed that long-term PD significantly enhanced the activation of MAIT cells, particularly the proinflammatory MAIT17 subtype. These activated cells contributed to peritoneal fibrogenesis by binding to the MR1 receptor on mesothelial cells, which triggered hyperglycolysis through the mTOR complex 1 pathway, ultimately leading to fibrogenesis. Notably, we demonstrated that blocking the MR1–MAIT interaction, either through genetic knockout or pharmacological inhibition with acetyl-6-formylpterin, effectively mitigated fibrosis. CONCLUSIONS: This study identified MAIT cells as crucial drivers of PD-induced peritoneal fibrosis.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Sun Y, Huang Q, Sun J, et al. Mucosal-Associated Invariant T (MAIT) Cell-Mediated Immune Mechanisms of Peritoneal Dialysis-Induced Peritoneal Fibrosis and Therapeutic Targeting. J Am Soc Nephrol. 2025. PMID: 39874111. doi:10.1681/ASN.0000000627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。